scispace - formally typeset
L

Luiz Sergio Leonardi

Researcher at State University of Campinas

Publications -  75
Citations -  698

Luiz Sergio Leonardi is an academic researcher from State University of Campinas. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 14, co-authored 74 publications receiving 667 citations.

Papers
More filters
Journal ArticleDOI

12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.

Gary A. Levy, +101 more
TL;DR: The efficacy of CsA‐ME monitored by blood concentration at 2 hours postdose and tacrolimus in liver transplant patients is equivalent to 12 months, and renal function is similar.
Journal ArticleDOI

Intraoperative massive transfusion decreases survival after liver transplantation.

TL;DR: It was observed that patients receiving over 6 red blood cell units intraoperatively displayed reduced survival, and predictive factors for this risk factor were high donor level of sodium and of age.
Journal ArticleDOI

Liver transplant recipients mortality on the waiting list: long-term comparison to child-pugh classification and meld

TL;DR: The experience concerning the high waiting list mortality rate for orthotopic liver transplantation (OLT) using the MELD (Model for End-Stage Liver Disease), which has been shown to predict short-term survival better than Child-Turcotte-Pugh (CTP) classification, was evaluated.
Journal ArticleDOI

[The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term].

TL;DR: In this article, a model for end-stage liver disease (MELD) was developed to predict short-term mortality in patients with cirrhosis, which was used to assess the value of pretransplant MELD in the prediction of posttransplant survival.
Journal ArticleDOI

Aplicação do escore MELD em pacientes submetidos a transplante de fígado: análise retrospectiva da sobrevida e dos fatores preditivos a curto e longo prazo

TL;DR: In this article, a model for end-stage liver disease (MELD) was developed to predict short-term mortality in patients with cirrhosis in patients who underwent liver transplantation.